[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-365258-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-365258-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","genomic-alterations-in-normal-breast-tissues-preceding-breast-cancer-diagnosis-research-open-access","Genomic alterations in normal breast tissues preceding breast cancer diagnosis - Research Open Access","","Genomic alterations in histologically normal breast tissues adjacent to cancer are often shared with the tumor, yet the timing and relevance of such changes long before diagnosis remained uncertain. Whole exome sequencing compared germline and somatic alterations in pre-diagnosis normal tissues from women who later developed breast cancer (n=79) versus women without subsequent cancer (n=81). Pre-diagnosis tissues showed higher high-impact germline variant burden and dominance of COSMIC signature 3, with immune-related polymorphisms more frequently mutated.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/genomic-alterations-in-normal-breast-tissues-preceding-breast-cancer-diagnosis-research-open-access/365258/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/genomic-alterations-in-normal-breast-tissues-preceding-breast-cancer-diagnosis-research-open-access/365258.png","ImageObject",300,407,{"name":42,"@type":43},"Rhys","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What study question does the paper address?","Question",{"text":63,"@type":64},"Whether histologically normal breast tissues contain cancer-related genomic changes years before a breast cancer diagnosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were genomic alterations measured in the study?",{"text":68,"@type":64},"Whole exome sequencing assessed germline and somatic alterations in histologically normal pre-diagnosis tissues and compared them with tissues from controls.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key genomic findings in pre-diagnosis tissues?",{"text":72,"@type":64},"Pre-diagnosis tissues had more high functional impact germline variants, cancer-hallmark gene involvement, and a dominant COSMIC signature 3 signal, along with immune regulatory gene polymorphisms more frequently mutated.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},365258,1790211988,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},687207024643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Dai etal. Breast Cancer Research (2025) 27:60 Breast Cancer Research  \n[https://doi.org/10.1186/s13058-025-02018-5](https://doi.org/10.1186/s13058-025-02018-5)  \nRESEARCH Open Access  \nGenomic alterations in normal breast tissues   preceding breast cancer diagnosis  \nJiawei Dai 1†, Mariya Rozenblit 1†, Xiaoyue Li 1, Naing Lin Shan 1, Yueyue Wang 1, Shrikant Mane2, Michal Marczyk3 and Lajos Pusztai 1*  \nAbstract  \nBackground Normal breast tissues adjacent to cancer often harbor many of the same genomic alterations as the cancer itself. However, it remains unclear whether histologically normal breast tissues carry genomic changes related to cancer development years before a cancer diagnosis.  \nMethods Whole exome sequencing was performed to examine germline and somatic alterations in histologically normal breast tissues from women who subsequently developed breast cancer (n = 79, pre-diagnosis tissues) and compared these with results from breast tissues of women who did not (n = 81) . No patient had germline mutations in cancer predisposition genes.  \nResults The pre-diagnosis tissues had significantly more high functional impact germline variants per sample than the healthy controls (P = 0 . 034), 36 . 5% of affected genes were cancer hallmark genes, among these 62.4% were involved with evading growth suppressors and 5 . 7% with genome instability. The average number of somatic mutations were similar between the two cohorts. Mutation signature analysis revealed COSMIC signatures 3 (associated with impaired homologous recombination) as a dominant signature more frequent in pre-diagnosis tissues. At gene and variant level, nine common germline polymorphisms in two immune regulatory genes, FCGBP and TPSBP2, and along with three somatic mutations in F13A1, FRY and TMLHE, were significantly more frequently mutated in the pre-diagnosis samples.  \nConclusions Individuals who develop breast cancer have a higher germline variant burden in normal breast tissues leading to subtle deficiencies in DNA repair that in the context of other germline and somatic mutations could facilitate malignant transformation.  \nKeywords Breast cancer precursors, Whole exome sequencing, Early tumorigenesis, Mutation signatures, Immune polymorphisms  \n†Jiawei Dai and Mariya Rozenblit contributed equally to this work.  \n*Correspondence: Lajos Pusztai[lajos.pusztai@yale.edu](lajos.pusztai@yale.edu)  \n1Yale Cancer Center, Yale School of Medicine, Suite 120, Rm 133, 300 George Street, New Haven, CT 06511, USA  \n2Yale Center for Genome Analysis, West Haven, CT, USA 3Department of Data Mining and Engineering, Silesian University of Technology, Gliwice, Poland  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/.  \nDai et al. Breast Cancer Research (2025) 27:60  \nBackground  \nThe lifetime probability of being diagnosed with some type of invasive cancer is around 40% for women in the USA, and the most commonly diagnosed malignancy is breast cancer with over 300,000 new cases each year corresponding to a one in eight life time risk [1]. Breast cancer also accounts for one in four cancers in women worldwide with the highest incidenc","cbCairkpdluY26kv","https://ap.wps.com/l/cbCairkpdluY26kv","pdf",3395520,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background\n## Cancer risk and genetic contributions\n## Cancer hallmarks and adjacent normal tissues","[{\"question\":\"What study question does the paper address?\",\"answer\":\"Whether histologically normal breast tissues contain cancer-related genomic changes years before a breast cancer diagnosis.\"},{\"question\":\"How were genomic alterations measured in the study?\",\"answer\":\"Whole exome sequencing assessed germline and somatic alterations in histologically normal pre-diagnosis tissues and compared them with tissues from controls.\"},{\"question\":\"What were the key genomic findings in pre-diagnosis tissues?\",\"answer\":\"Pre-diagnosis tissues had more high functional impact germline variants, cancer-hallmark gene involvement, and a dominant COSMIC signature 3 signal, along with immune regulatory gene polymorphisms more frequently mutated.\"}]","Genomic alterations in normal breast tissues preceding breast cancer diagnosis - Research Open Access | PDF",1790160492,33,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99f03f9b147172c2db7fd8d0bb19ae29.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de860430b9b0893d42bfe42cb400f600.webp",982,1309,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc73b5bdbedf93fa9f215fa63ceb4ebc.webp",981,1308,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6e575507121594408441e1be4de02cc.webp",980,1306]